These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3412549)

  • 1. Inhibitors of coagulation in terminal renal failure and during hemodialysis.
    Knudsen F; Sørensen PJ; Nielsen AH; Dyerberg J
    Nephron; 1988; 49(4):335-6. PubMed ID: 3412549
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful kidney transplantation does not reverse the coagulopathy in patients with chronic renal failure on either hemo or peritoneal dialysis.
    Ballow A; Gader AM; Huraib S; Mitwalli A; Al-Suleimani F; Al-Wakeel J
    Saudi J Kidney Dis Transpl; 2007 Jun; 18(2):177-85. PubMed ID: 17496391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein C and renal pathology in Ivory Coast population.
    Blavy G; Koffi D
    Nouv Rev Fr Hematol (1978); 1991; 33(5):359-61. PubMed ID: 1666429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in blood coagulation mechanism in patients with chronic renal failure kept on chronic or iterative hemodialysis (author's transl)].
    Grgicević D; Antos M; Pistotnik M; Prejac M; Flego I
    Lijec Vjesn; 1977 May; 99(5):307-10. PubMed ID: 886907
    [No Abstract]   [Full Text] [Related]  

  • 5. Further investigations of the defective protein C in hemodialysis, hemofiltration and continuous ambulatory peritoneal dialysis.
    Sørensen PJ; Nielsen AH; Knudsen F; Dyerberg J
    Blood Purif; 1989; 7(4):218-22. PubMed ID: 2775514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein C, protein S, and antithrombin III levels in patients on continuous ambulatory peritoneal dialysis and hemodialysis.
    Lai KN; Yin JA; Yuen PM; Li PK
    Nephron; 1990; 56(3):271-6. PubMed ID: 2150218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Disorders of blood coagulation and fibrinolysis in patients with chronic renal failure during treatment with hemodialysis, and methods of correction].
    Neĭmark MI
    Ter Arkh; 1984; 56(7):48-53. PubMed ID: 6484834
    [No Abstract]   [Full Text] [Related]  

  • 8. Recombinant human erythropoietin treatment may induce antithrombin-III depletion.
    Arinsoy T; Ozdemir O; Arik N; Ozcebe O; Yasavul U; Dündar S; Turgan C; Kirazli S; Cağlar S
    Nephron; 1992; 62(4):480-1. PubMed ID: 1300451
    [No Abstract]   [Full Text] [Related]  

  • 9. The changes of contact factors and related inhibitors of the patients with chronic hemodialysis and live diseases.
    Kondo S; Niwa M; Sakuragawa N
    Nihon Ketsueki Gakkai Zasshi; 1985 Feb; 48(1):223-8. PubMed ID: 4003008
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of human recombinant erythropoietin on plasminogen activator inhibitor, and protein C and S activity.
    Steffensen G; Aunsholt NA
    Am J Nephrol; 1996; 16(5):453-4. PubMed ID: 8886186
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hemostasis in patients with chronic kidney failure treated with long-term hemodialysis].
    Opatrný K; Cepelák V; Opatrný K
    Vnitr Lek; 1988 Sep; 34(9):918-23. PubMed ID: 3201769
    [No Abstract]   [Full Text] [Related]  

  • 12. Control of plasma aldosterone during hemodialysis in patients with terminal renal failure.
    Vetter W; Záruba K; Armbruster H; Beckerhoff R; Nussberger J; Furrer J; Fontana A; Siegenthaler W
    Nephron; 1977; 18(2):114-23. PubMed ID: 857174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation activation in extracorporeal hemodialysis.
    Camici M; Evangelisti L; Balestri P; Cioni L; Rindi P; Sagripanti A; Meriggioli M; Giordani R
    Int J Artif Organs; 1997 Mar; 20(3):163-5. PubMed ID: 9151152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of hemodialysis on some parameters of the antioxidant system in the blood of patients with chronic renal failure].
    Olszewska M
    Ann Acad Med Stetin; 2004; 50(1):41-52. PubMed ID: 16871743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in platelets, coagulation and fibrinolysis in patients with chronic kidney diseases and hemodialysis].
    Terada H
    Nihon Rinsho; 1992 Jan; 50 Suppl():565-72. PubMed ID: 1578739
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of hemodialysis on the blood coagulation system].
    Stetsiuk EA; Lopatkin NA; Mikheeva LA; Iarmolinskiĭ IS; Chudnovskaia MV
    Urol Nefrol (Mosk); 1988; (4):46-51. PubMed ID: 3218018
    [No Abstract]   [Full Text] [Related]  

  • 17. [The crythrocyte system in terminal renal failure caused by chronic glomerulonephritis, treated by hemodialysis].
    Dobiecka-Wawrzecka B
    Wiad Lek; 1980 Jun; 33(11):849-54. PubMed ID: 7423987
    [No Abstract]   [Full Text] [Related]  

  • 18. [Behavior of some coagulation parameters during hemodialysis].
    Gerhardt W; Neumann W; Stein G
    Dtsch Gesundheitsw; 1971 Jan; 26(2):54-6. PubMed ID: 5095588
    [No Abstract]   [Full Text] [Related]  

  • 19. Coagulation and fibrinolysis in patients with chronic renal failure on maintenance hemodialysis.
    Deguchi K; Izumi K; Noguchi M; Yuwasaki E; Suzuki H; Mori Y; Deguchi A; Ohkubo I; Tsuda M; Wada H
    Nihon Ketsueki Gakkai Zasshi; 1989 Feb; 52(1):140-6. PubMed ID: 2741646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein C and its inhibitors during hemodialysis.
    Arik N; Ozdemir O; Akpolat T; Arinsoy T; Ozcebe O; Dündar S; Yasavul U; Turgan C; Caglar S
    Nephron; 1992; 60(4):488. PubMed ID: 1584328
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.